TRECOS

• Research type

  Research Study

• Full title

  A 12-WEEK DOUBLE-BLIND, MULTICENTRE, RANDOMISED, ACTIVE-CONTROLLED, 2-ARM, PARALLEL-GROUP CLINICAL TRIAL TO EVALUATE THE SAFETY OF CHF5993 pMDI 200/6/12.5 µg HFA-152a, COMPARED TO CHF5993 pMDI 200/6/12.5 µg HFA-134a, IN SUBJECTS WITH ASTHMA

• IRAS ID

  1008211

• Contact name

  Frédérique Grapin

• Contact email

  f.grapin@chiesi.com

• Sponsor organisation

  Chiesi Farmaceutici S.p.A

• Eudract number

  2023-503333-22

• Research summary

  A clinical trial, involving several sites in several countries, with a duration of 12-week, where patients, medical doctors and sponsor do not know the treatment taken by patient (between study treatment and another one) with the scope of evaluate the safety of study treatment in comparison with another similar one in subjects with asthma.

• REC name

  London - City & East Research Ethics Committee

• REC reference

  23/LO/0691

• Date of REC Opinion

  13 Nov 2023

• REC opinion

  Further Information Favourable Opinion